SUBSCRIBERS
US FDA warns Indian drugmaker Lupin on repeated quality violations
Published Wed, Nov 15, 2017 · 09:50 PM
Washington
LUPIN Ltd, which makes generic antibiotics, antidepressants and heart medications for sale in the United States, was warned by the Food and Drug Administration (FDA) for repeatedly ignoring tests showing that pills made at two of its facilities didn't meet quality standards.
In 2015 and 2016, the FDA found 134 instances …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself